Sandler M P, Robinson R P, Rabin D, Lacy W W, Abumrad N N
J Clin Endocrinol Metab. 1983 Mar;56(3):479-85. doi: 10.1210/jcem-56-3-479.
The present study was designed to examine the effects of excess T3 on total body glucose production and forearm exchange of glucose, amino acids, and other metabolites. Five healthy male volunteers were studied after an overnight fast, before and 7 days after the administration of 150 micrograms/day T3. Glucose production (milligrams per kg/min) was measured using a primed continuous infusion of [3-3H]glucose and gluconeogenic index (micromoles per kg/min) was measured by following the conversion of infused [14C]alanine to [14C]glucose. Blood flow across the forearm was measured using capacitance plethysmography and forearm release of substrates was determined by the Fick principle. After T3 administration, there was a 3.7-fold rise in T3 from 150 +/- 15 to 530 +/- 12 ng/dl (P less than 0.001), with no change in insulin (12 +/- 1 microU/ml pre-T3 vs. 13 +/- 2 microU/ml post-T3) and glucagon (79 +/- 5 pre-T3 vs. 84 +/- 7 pg/ml post-T3). T3 administration resulted in an increase in plasma glucose (from 83 +/- 5 to 98 +/- 5 mg/dl; P less than 0.05), net glucose uptake by the forearm (from 250 +/- 90 to 712 +/- 60 nmol/100 ml forearm tissue X min; P less than 0.005) and glucose production (1.7 +/- 0.09 to 2.2 +/- 0.08 mg/kg X min; P less than 0.005), without a change in glucose clearance (2.1 +/- 0.02 vs. 2.0 +/- 0.02 ml/kg X min); the rate of conversion of [14C]alanine to [14C]glucose increased by 30% (0.56 +/- 0.03 to 0.74 +/- 0.03 mumol/ kg X min P less than 0.005). These values were associated with a 25% increase in blood lactate to 712 +/- 69 mumol/liter (P less than 0.05) and a 131% increase in lactate release across the forearm to 434 +/- 90 (P less than 0.005). Forearm release of alanine (96 +/- 29 nmol/100 ml forearm tissue X min) and glutamine (151 +/- 41 nmol/100 ml forearm tissue X min) increased by 90% (P less than 0.005 and P = 0.04, respectively), with no change in their concentrations. Forearm release of branched chain amino acids did not change, while those of their ketoacids, alpha-ketoisocaproate (KIC) and alpha-ketoisovalerate (KIV), doubled (to 64 +/- 9 mumol/liter for KIC and 39 +/- 6 mumol/liter for KIV; P less than 0.05). These were associated with a 45% increase in the branched chain amino acid levels and a 46% rise in both KIC and KIV levels to 41 +/- 9 and 28 +/- 7 mumol/liter, respectively (P less than 0.05). There was a concurrent significant (P less than 0.05) change in the arterial levels of phenylalanine (-32%), tyrosine (-29%), threonine (-20%), glycine (-20%), and serine (-15%), without any change in their efflux across the forearm. The data indicate that a pharmacologically induced rise in T3, to levels comparable to those seen in hyperthyroidism, results in enhanced glucose production, with an increase in glucose uptake by the forearm. The former can be partially accounted for by an increase in hepatic gluconeogenesis, glycogenolysis, or possibly increased renal glucose production...
本研究旨在探讨过量的三碘甲状腺原氨酸(T3)对全身葡萄糖生成以及前臂葡萄糖、氨基酸和其他代谢产物交换的影响。对5名健康男性志愿者进行了研究,他们在禁食过夜后,于每天服用150微克T3之前和之后7天进行检测。使用[3-3H]葡萄糖的预充连续输注法测量葡萄糖生成(毫克/千克/分钟),通过追踪输注的[14C]丙氨酸向[14C]葡萄糖的转化来测量糖异生指数(微摩尔/千克/分钟)。使用电容体积描记法测量前臂血流量,并根据菲克原理确定前臂底物释放量。给予T3后,T3水平从150±15 ng/dl升至530±12 ng/dl,升高了3.7倍(P<0.001),胰岛素(T3给药前12±1微单位/毫升,给药后13±2微单位/毫升)和胰高血糖素(T3给药前79±5,给药后84±7皮克/毫升)水平无变化。给予T3导致血浆葡萄糖升高(从83±5毫克/分升升至98±5毫克/分升;P<0.05),前臂净葡萄糖摄取量增加(从250±90纳摩尔/100毫升前臂组织×分钟升至712±60纳摩尔/100毫升前臂组织×分钟;P<0.005)以及葡萄糖生成增加(1.7±0.09至2.2±0.08毫克/千克×分钟;P<0.005),而葡萄糖清除率无变化(2.1±0.02与2.0±0.02毫升/千克×分钟);[14C]丙氨酸向[14C]葡萄糖的转化率增加了30%(0.56±0.03至0.74±0.03微摩尔/千克×分钟,P<0.005)。这些数值与血乳酸增加25%至712±69微摩尔/升(P<0.05)以及前臂乳酸释放增加131%至434±90(P<0.005)相关。前臂丙氨酸释放量(96±29纳摩尔/100毫升前臂组织×分钟)和谷氨酰胺释放量(151±41纳摩尔/100毫升前臂组织×分钟)分别增加了90%(P<0.005和P = 0.04),但其浓度无变化。前臂支链氨基酸释放量未改变,而其酮酸α-酮异己酸(KIC)和α-酮异戊酸(KIV)的释放量增加了一倍(KIC为64±9微摩尔/升,KIV为39±6微摩尔/升;P<0.05)。这些变化与支链氨基酸水平增加45%以及KIC和KIV水平均升高46%至41±9和28±7微摩尔/升相关(P<0.05)。同时,苯丙氨酸(-32%)、酪氨酸(-29%)、苏氨酸(-20%)、甘氨酸(-20%)和丝氨酸(-15%)的动脉水平有显著(P<0.05)变化,而它们通过前臂的流出量无变化。数据表明,药理学诱导的T3水平升高至与甲状腺功能亢进症相当的水平,会导致葡萄糖生成增强,同时前臂葡萄糖摄取增加。前者部分可归因于肝糖异生、糖原分解增加,或可能是肾葡萄糖生成增加……